Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
DP Technology Announces Nomination of Development Candidate, a Potential Best-in-Class Lp-PLA2 Inhibitor for DR and DME 2024-07-08 17:00
Immorna Biotherapeutics Receives U.S. FDA IND Clearance to Conduct Phase 1/2 Study of JCXH-211 IV as Monotherapy and in Combination with Checkpoint Inhibitor in Patients with Advanced Solid Tumors 2024-07-08 16:28
Sirnaomics Announces Interim Results for Successful Completion of the Second Cohort of Phase I Clinical Study of GalNAc-Based RNAi Therapeutic STP122G for Anticoagulant Therapeutics 2024-07-08 14:30
Parents: Discover the Three Essential Pillars of Childcare for Your Child's Optimal Development 2024-07-08 14:13
BioCity announces its endothelin receptor A selective antagonist SC0062 met the primary endpoint in IgA nephropathy in 2-SUCCEED trial: a randomized, double-blind, placebo-controlled Phase 2 trial 2024-07-08 13:41
Olverembatinib Approved for Commercialization in Macau China 2024-07-08 08:55
Innovent Launches Environmental, Social and Governance (ESG) Website to Advance Sustainability and Corporate Responsibility 2024-07-08 08:00
ESHRE 40th Annual Meeting: Air pollution linked to a decrease in IVF birth rate success, new study shows 2024-07-08 06:01
FAIR PLAY MENARINI INTERNATIONAL AWARD, A MAGICAL NIGHT AT FIESOLE FOR THE GRAND FINALE 2024-07-05 21:48
XPOVIO® (selinexor) Approved for New Indication in DLBCL in China, Bringing a New Treatment Option to Patients in the Country 2024-07-05 21:18
Hinova Pharmaceuticals receives FDA Fast Track Designation for HP518 for Treatment of AR+ Triple-Negative Breast Cancer (TNBC) 2024-07-05 21:00
LakeShore Biopharma to Hold an Extraordinary General Meeting on July 25, 2024, Pursuant to Shareholders' Requisition 2024-07-05 19:00
IASO Bio and Innovent Enhance Strategic Collaboration in Cell Therapy 2024-07-05 16:30
Innovent and IASO Bio Enhance Strategic Collaboration in Cell Therapy 2024-07-05 16:30
Biostar Pharma Announces FDA Clearance of the IND Application for a Phase 2 Study of Utidelone Injection (UTD1) in HER2- Breast Cancer Brain Metastasis 2024-07-05 16:07
Zhejiang Doer Biologics Completes Enrollment of the Phase 1b/2a Trial Evaluating DR10624 in Obese Subjects with Modest Hypertriglyceridemia 2024-07-05 15:56
Neurosurgeon Dr. Teo Kejia Shares Advancements in Brain Surgery Techniques for Optimal Patient Care 2024-07-04 15:28
LOTTE BIOLOGICS Holds Groundbreaking for Songdo Bio Campus 2024-07-04 11:17
Docquity accelerates growth for pediatric multivitamin distributor Green Nature Farm in Indonesia 2024-07-04 10:00
Ascentage Pharma Received US$100 Million Option Payment from Takeda 2024-07-04 08:28
1 48 49 50 51 52 962